# Clustering Approach 3 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0079793599841319	Range of duration = 0.03 to 187.07, nDeath = 30, nCensor = 279
2	AGE	ANOVA	0.0123295594932195	Range of values = 31 to 90, Mean = 63.4872, StdDev = 11.1188, nMissing = 1
3	HISTOLOGICAL.TYPE	Chi-square test	4.28431133407876e-17	nTypes = 6 (ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3)/MIXED SEROUS AND ENDOMETRIOID/SEROUS ENDOMETRIAL ADENOCARCINOMA), nPatients = 229/6/1/3/16/58
4	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.0786279283023054	nTypes = 2 (NO/YES), nPatients = 79/234
5	NEOADJUVANT.THERAPY	Fisher's exact test	0.013152380469549	nTypes = 2 (NO/YES), nPatients = 70/243
